We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Kiadis Pharma Receives Regulatory Approval from Health Canada

News   Feb 28, 2013

 
Kiadis Pharma Receives Regulatory Approval from Health Canada
 
 
Advertisement
 

RELATED ARTICLES

Researchers Discover Cells That Heal Cardiac Damage After Infarction

News

Researchers at Cima and the Clinica Universidad de Navarra (Spain) have identified the cardiac cells responsible for repairing the damage to the heart in a recent international study. This finding will permit the identification of new therapeutic targets and the development of targeted therapies for the organ after infarction occurs.

READ MORE

Understanding How Cisplatin Chemotherapy Causes Neuronal Damage

News

Researchers have shown that Cisplatin induces senescence of peripheral neurons through overexpression of the p21 protein, which would explain the neuropathy associated with this treatment.

READ MORE

Novel Drug Disarms Cancer-Causing Protein Aurora

News

Aurora-A kinase is a protein that causes extensive damage to cells of the body and is known to trigger the development of leukemias and many pediatric cancers, such as neuroblastoma. Researchers at the universities of Würzburg and Frankfurt have now developed a drug that can disarm Aurora.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE